• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Rapid Genotype Assay for Individualized Warfarin Dosing

  • in Cardiovascular
  • — 25 Mar, 2007
Rapid Genotype Assay for Individualized Warfarin Dosing
AudioMedica News
Rapid Genotype Assay for Individualized Warfarin Dosing
Rapid Genotype Assay for Individualized Warfarin Dosing
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-268"/>
Jeffrey Anderson
Jeffrey Anderson

Douglas Zipes
Douglas Zipes

JEFFREY ANDERSON, University of Utah, Salt Lake City
COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis

REFERENCE: Abstract 1020-89, American College of Cardiology New Orleans
The hope of refining treatments for cardiovascular disease by genotyping patients to detect individual sensitivities to particular medical therapies was brought a step closer at the ACC meeting in New Orleans by results from a study using a rapid genothype test. Jeffrey Anderson told Peter Goodwin about the assay they’ve been investigating which indicates required dosing of warfarin.

[audio:https://www.audiomedica.com/podcasting/cardio/acc2007/070325_jeffrey_anderson_douglas_zipes.mp3]

You may also like...

  • Thrombolysis Before Primary PCI Increases Mortality Thrombolysis Before Primary PCI Increases Mortality 12 Sep, 2005
  • Mandeep Mehra MD COVID-19 Co-Morbidity Risks Quantified from Three Continents Survey 28 May, 2020
  • Telomere Length Predicts Coronary Heart Disease Risk and Statin Response Telomere Length Predicts Coronary Heart Disease Risk and Statin Response 19 Jan, 2007
  • Remove Thrombus Before Primary Angioplasty! Remove Thrombus Before Primary Angioplasty! 15 Apr, 2008

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Thrombin Receptor Antagonist: Advantages in Percutaneous Coronary Intervention?
  • Next story Increased Use of Recommended Drugs Explains Improved Trends in Prognosis after Myocardial Infarction
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Physical Therapy Boosts Brain Power in Hemiplegic…
    • Head and Neck Cancer Therapy De-Escalation: A…
  • Home
  • Cardiovascular
  • Rapid Genotype Assay for Individualized Warfarin Dosing

© COPYRIGHT 2020 AUDIOMEDICA.COM.